{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:33:28Z","timestamp":1786635208122,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0253-7613.186206","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T01:25:14Z","timestamp":1471483514000},"page":"372","source":"Crossref","is-referenced-by-count":20,"title":["Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study"],"prefix":"10.4103","volume":"48","author":[{"given":"Hamid","family":"Yaghooti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Ayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AhmadReza","family":"Assareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadTaha","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Olapour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.186206-1","first-page":"135","volume-title":"Oxidative stress and hypertension: Current concepts","author":"Briones","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"key-10.4103\/0253-7613.186206-2","first-page":"507","volume-title":"2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","author":"James","year":"2014","journal-title":"JAMA"},{"key":"key-10.4103\/0253-7613.186206-3","first-page":"307","volume-title":"Use of carvedilol in hypertension: An update","author":"Leonetti","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"key-10.4103\/0253-7613.186206-4","first-page":"731","volume-title":"Antioxidant activity of carvedilol in cardiovascular disease","author":"Dandona","year":"2007","journal-title":"J Hypertens"},{"key":"key-10.4103\/0253-7613.186206-5","first-page":"312","volume-title":"Antiatherogenic function of HDL particle subpopulations: Focus on antioxidative activities","author":"Kontush","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"key-10.4103\/0253-7613.186206-6","doi-asserted-by":"crossref","unstructured":"Mackness M, Mackness B. Current aspects of paraoxonase-1 research. In: Komoda T, editor. The HDL Handbook: Biological Functions and Clinical Implications. 2nd ed. London: Academic Press; 2013. p. 273-91.","DOI":"10.1016\/B978-0-12-407867-3.00011-1"},{"key":"key-10.4103\/0253-7613.186206-7","first-page":"97","volume-title":"Reduced paraoxonase 1 activity as a marker for severe coronary artery disease","author":"Zhou","year":"2013","journal-title":"Dis Markers"},{"key":"key-10.4103\/0253-7613.186206-8","first-page":"317","volume-title":"The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: Cardiovascular implications","author":"Navarra","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"key-10.4103\/0253-7613.186206-9","first-page":"159","volume-title":"Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome \u2013 Comparison with other biomarkers","author":"Kume","year":"2010","journal-title":"J Cardiol"},{"key":"key-10.4103\/0253-7613.186206-10","first-page":"23","volume-title":"Carvedilol in hypertension treatment","author":"Stafylas","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"key-10.4103\/0253-7613.186206-11","first-page":"421","volume-title":"The effect of carvedilol on metabolic parameters in patients with metabolic syndrome","author":"Uzunlulu","year":"2006","journal-title":"Int Heart J"},{"key":"key-10.4103\/0253-7613.186206-12","first-page":"210","volume-title":"Differential effects of extended-release carvedilol and extended-release metoprolol on lipid profiles in patients with hypertension: Results of the Extended-Release Carvedilol Lipid Trial","author":"Fonarow","year":"2009","journal-title":"J Am Soc Hypertens"},{"key":"key-10.4103\/0253-7613.186206-13","first-page":"234","volume-title":"Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients","author":"Bell","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"key-10.4103\/0253-7613.186206-14","first-page":"615","volume-title":"Effects of beta-blockers on glucose and lipid metabolism","author":"Fonseca","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"key-10.4103\/0253-7613.186206-15","first-page":"564","volume-title":"Impact of carvedilol on the serum lipid profile","author":"Sharp","year":"2008","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0253-7613.186206-16","first-page":"337","volume-title":"Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on","author":"Costa","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key-10.4103\/0253-7613.186206-17","first-page":"179","volume-title":"Carvedilol and metoprolol in acute myocardial infarction early effect of oxidized LDL and paraoxonase-1 activity","author":"Albayrak","year":"2013","journal-title":"Abant Med J"},{"key":"key-10.4103\/0253-7613.186206-18","first-page":"248","volume-title":"Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance?","author":"Touyz","year":"2004","journal-title":"Hypertension"},{"key":"key-10.4103\/0253-7613.186206-19","first-page":"378","volume-title":"The effects of newer beta-adrenoceptor antagonists on vascular function in cardiovascular disease","author":"Wehland","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"key-10.4103\/0253-7613.186206-20","first-page":"777","volume-title":"Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus","author":"Bank","year":"2007","journal-title":"Am J Hypertens"},{"key":"key-10.4103\/0253-7613.186206-21","first-page":"117","volume-title":"The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism","author":"Ozbilen","year":"2012","journal-title":"Endocr Res"},{"key":"key-10.4103\/0253-7613.186206-22","first-page":"634","volume-title":"Effects of monotherapy and combination therapy on blood pressure control and target organ damage: A randomized prospective intervention study in a large population of hypertensive patients","author":"Tedesco","year":"2006","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"key-10.4103\/0253-7613.186206-23","first-page":"413","volume-title":"Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases","author":"Pirillo","year":"2013","journal-title":"Dis Markers"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:43:10Z","timestamp":1786632190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.186206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"alternative-id":["186206"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.186206","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}